Sign In
Get Clay Free →

Suggestions

    Daniel Camardo

    Biopharma Executive I Board Director I Commercial Strategy I Adjunct Professor

    Daniel Camardo is a seasoned Pharmaceutical/Biotech executive with a strong background in mid/late stage clinical development, commercial strategy, and general management.

    His expertise includes recruiting and leading effective teams, transforming single product start-ups into multi-franchise organizations, and contributing to successful commercial entries of pharmaceutical companies.

    Daniel played a pivotal role in the merger of Yamanouchi Pharma and Fujisawa in 2005, forming Astellas Pharma, a global specialty pharmaceutical company. He also helped Horizon Therapeutics grow into a leader in rare disease with numerous successful product launches.

    With an MBA from Northwestern University and a BA in Economics/Mathematics from the University of Rochester, Daniel Camardo possesses a solid educational foundation.

    Throughout his career, Daniel has held various key positions in renowned organizations such as CLC Biopharma, LLC, Athersys, Inc., Horizon Therapeutics, Clarus Therapeutics, and Astellas Pharma US.

    His roles have included CEO, Board Director, VP, President, GM, and Senior Director, showcasing his diverse skill set in sales, commercial operations, market intelligence, analytics, and general management.

    Daniel Camardo's contributions span diverse specialty markets like Oncology, Urology, Immunology, Neurology, Dermatology, CV Imaging, Rheumatology, and Orphan/Rare Disease.

    Passionate about innovation and patient well-being, Daniel has successfully launched 14 products in specialty markets and helped organizations achieve significant market caps and commercial success.

    Daniel Camardo
    Add to my network

    Location

    Greater Chicago Area